CRIS Current Research Information System

PICCALUGA, PIER PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.143
EU - Europa 13.001
AS - Asia 11.692
SA - Sud America 766
AF - Africa 749
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 8
Totale 40.382
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.993
IT - Italia 4.439
CN - Cina 3.385
SG - Singapore 3.254
GB - Regno Unito 2.690
VN - Vietnam 2.603
DE - Germania 1.274
SE - Svezia 1.223
FR - Francia 737
HK - Hong Kong 708
IN - India 659
UA - Ucraina 573
RU - Federazione Russa 568
BR - Brasile 551
IE - Irlanda 372
ZA - Sudafrica 280
NL - Olanda 240
JP - Giappone 223
EE - Estonia 173
TG - Togo 170
KR - Corea 165
CH - Svizzera 156
CI - Costa d'Avorio 143
FI - Finlandia 142
CA - Canada 90
AR - Argentina 85
IR - Iran 82
JO - Giordania 77
ID - Indonesia 69
PH - Filippine 64
BG - Bulgaria 63
TR - Turchia 63
BE - Belgio 58
BD - Bangladesh 52
TH - Thailandia 45
IQ - Iraq 44
SC - Seychelles 43
GR - Grecia 41
PL - Polonia 40
EC - Ecuador 38
MX - Messico 36
PK - Pakistan 36
ES - Italia 33
NG - Nigeria 28
TW - Taiwan 28
HR - Croazia 27
CL - Cile 26
LU - Lussemburgo 25
AT - Austria 24
RO - Romania 24
LB - Libano 22
SA - Arabia Saudita 22
UZ - Uzbekistan 22
CO - Colombia 20
PY - Paraguay 18
LT - Lituania 15
AU - Australia 13
EG - Egitto 13
KE - Kenya 12
MY - Malesia 12
MA - Marocco 11
TN - Tunisia 11
AE - Emirati Arabi Uniti 10
VE - Venezuela 10
ET - Etiopia 9
UY - Uruguay 9
DZ - Algeria 8
HU - Ungheria 8
NZ - Nuova Zelanda 8
PT - Portogallo 8
SK - Slovacchia (Repubblica Slovacca) 8
AL - Albania 7
CZ - Repubblica Ceca 7
IL - Israele 7
KZ - Kazakistan 7
NP - Nepal 7
PE - Perù 7
DO - Repubblica Dominicana 5
GH - Ghana 5
RS - Serbia 5
KG - Kirghizistan 4
OM - Oman 4
SI - Slovenia 4
XK - ???statistics.table.value.countryCode.XK??? 4
AO - Angola 3
AZ - Azerbaigian 3
CR - Costa Rica 3
HN - Honduras 3
IS - Islanda 3
MD - Moldavia 3
PA - Panama 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BF - Burkina Faso 2
BO - Bolivia 2
BY - Bielorussia 2
CY - Cipro 2
DK - Danimarca 2
EU - Europa 2
Totale 40.343
Salva come PNG Salva come JPEG
Città #
Southend 2.359
Singapore 2.192
Fairfield 1.583
Ashburn 1.431
Chandler 930
Houston 793
Woodbridge 759
Seattle 715
Wilmington 703
Hong Kong 668
San Jose 607
Cambridge 576
Princeton 575
Ho Chi Minh City 519
Ann Arbor 518
Santa Clara 461
Hanoi 453
Dong Ket 450
Beijing 432
Milan 417
Dublin 363
Hefei 340
Rome 308
Boardman 305
Jacksonville 299
Bologna 291
Lauterbourg 279
Nanjing 271
Padova 254
Westminster 238
Tokyo 193
Los Angeles 178
Lomé 169
New York 162
Abidjan 143
Jinan 137
Shenyang 135
Berlin 131
Saint Petersburg 127
Seoul 124
Turin 121
Helsinki 119
Bern 118
Naples 118
Buffalo 112
Bremen 110
Hebei 107
Changsha 93
Nanchang 88
Florence 82
Mülheim 82
Frankfurt am Main 80
Redondo Beach 78
San Diego 78
Amman 76
Dallas 76
Guangzhou 76
Da Nang 72
Tianjin 71
São Paulo 70
Parma 69
Haiphong 63
Sofia 61
Medford 60
Shanghai 59
Hangzhou 57
Jiaxing 56
Brussels 54
Council Bluffs 52
Verona 50
Zhengzhou 49
Hyderabad 48
London 44
Haikou 42
Falls Church 41
Phoenix 41
Bengaluru 40
Redwood City 40
Munich 38
Taizhou 38
Dearborn 35
Ningbo 35
Taiyuan 35
Toronto 35
Yubileyny 35
Palermo 34
Johannesburg 33
Mahé 33
Orem 33
The Dalles 33
Jakarta 32
San Venanzo 32
Cagliari 31
Chicago 30
Montreal 29
Norwalk 29
Olalla 29
Bari 28
Warsaw 28
Biên Hòa 27
Totale 25.053
Salva come PNG Salva come JPEG
Nome #
Linfomi non Hodgkin di derivazione dai linfociti T-periferici. 1.878
Instillazione diretta intranasale di amfotericina B liposomiale nella terapia delle micosi nasali. 823
Linfomi non Hodgkin di derivazione dai linfociti T-periferici. 603
Leucemia Acuta Linfoide. 488
Efficacy and Clinical Outcome of Philadelphia (Ph) Positive Acute Lymphoblastic Leukemia (ALL) Patients Treated with Second Generation Tyrosine Kinase Inhibitors (TKIs): The Bologna Experience 351
ANALYSIS OF THE CODING GENOME OF SPLENIC MARGINAL ZONE LYMPHOMA REVEALS MUTATIONAL ACTIVATION OF NOTCH2 AND OTHER PATHWAYS REGULATING MARGINAL ZONE DIFFERENTIATION 318
Ficoll-hypaque separation vs whole blood lysis: Comparison of efficiency and impact on minimal residual disease analysis 283
Biology and treatment of follicular lymphoma. 277
IFI16 reduced expression is correlated with unfavorable outcome in chronic lymphocytic leukemia 265
The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study 252
CDKN1B/p27 expression in peripheral T cell lymphoma not otherwise specified. 248
Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified 240
The evolution of clonality testing in the diagnosis and monitoring of hematological malignancies 240
Comparison of two real-time quantitative polymerase chain reaction strategies for minimal residual disease evaluation in lymphoproliferative disorders: correlation between immunoglobulin gene mutation load and real-time quantitative polymerase chain reaction performance 232
IFI16 expression is related to selected transcription factors during B-cell differentiation 227
Large cell non Hodgkin’s lymphoma: what is new in the WHO classification? 226
Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma 220
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. 218
First experience with gemtuzumab ozogamicin plus cytarabine as continuous infusion for elderly acute myeloid leukaemia patients. 217
A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation 217
Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation 211
Advances in the treatment for haematological malignancies. 210
Genetic profiling in acute myeloid leukemia: a path to predicting treatment outcome 209
Expression of CD52 in peripheral T-cell lymphoma. 208
Alemtuzumab in the treatment of relapsed acute lymphoid leukaemia. 208
Gemtuzumab ozogamicin for relapsed and refractory acute myeloid leukemia and myeloid sarcomas 206
First-line treatment of chronic myeloid leukemia with nilotinib: critical evaluation. 206
Identification of a novel t(1;9)(q11;q34) in acute myelocytic leukemia 206
Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays. 206
Advances and potential treatment for Philadelphia chromosome-positive adult acute lymphoid leukaemia. 206
No preferential sensitivity of t(8;21) acute myeloid leukemias to cytosine arabinoside in vitro: is intensity of therapy or high dose Ara-C crucial for response? 203
Conditioning regimens in acute myeloid leukemia. 202
FIRMA MOLECOLARE E SUOI USI COME AGENTE DIAGNOSTICO 197
Epstein-Barr Virus-Induced Metabolic Rearrangements in Human B-Cell Lymphomas 197
Systemic Epstein-Barr-virus-positive T cell lymphoproliferative childhood disease in a 22-year-old Caucasian man: A case report and review of the literature 197
Complete and long-lasting cytologic and molecular remission of FIP1L1-PDGFRA-positive acute eosinophil myeloid leukaemia, treated with low-dose imatinib monotherapy 194
Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition 194
The Bcr-Abl kinase promotes aberrant expression of spliced oncogenic Ikaros isoforms in Philadelphia (Ph) positive acute lymphoblastic leukemia (ALL) patients treated with tyrosine kinase inhibitors 193
MINIMAL RESIDUAL DISEASE (MRD) EVALUATION IN LYMPHOMAS WITHIN THE FIL (FONDAZIONE ITALIANA LINFOMI) MRD NETWORK: INTER-LABORATORY REPRODUCIBILITY ON BORDERLINE SAMPLES 193
Association of 3q21q26 syndrome with different RPN1/EVI1 fusion transcripts 190
Molecular Profiling Improves Classification and Prognostication of Nodal Peripheral T-Cell Lymphomas: Results of a Phase III Diagnostic Accuracy Study 189
Platelet-derived growth factor alpha mediates the proliferation of peripheral T-cell lymphoma cells via an autocrine regulatory pathway. 189
Pathobiologic Roles of Epstein-Barr Virus-Encoded MicroRNAs in Human Lymphomas 189
Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas 188
Increased angiogenesis seems to correlate with inferior overall survival in myeloid sarcoma patients 188
Bone marrow stroma CD40 expression correlates with inflammatory mast cell infiltration and disease progression in splenic marginal zone lymphoma 187
Erythrophagocytosis by neoplastic cells in a patient with myelodysplastic syndrome 186
MicroRNAs sequencing unveils distinct molecular subgroups of plasmablastic lymphoma 186
A novel immunohistochemical classifier to distinguish Hodgkin lymphoma from ALK anaplastic large cell lymphoma. 185
Low-dose lenalidomide plus cytarabine in very elderly, unfit acute myeloid leukemia patients: Final result of a phase II study 184
Defective stromal remodeling and neutrophil extracellular traps in lymphoid tissues favor the transition from autoimmunity to lymphoma 183
Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus 183
Frequent Elevation of Akt Kinase Phosphorylation in Blood Marrow and Peripheral Blood Mononuclear Cells from High Risk myelodysplastic Syndrome Patients 182
Linfomi non Hodgkin di derivazione dai linfociti T-periferici primitivi della cute. 182
A targeted mutational landscape of angioimmunoblastic T-cell lymphoma 182
Duplex real-time polymerase chain reaction assay for the detection of human KIPyV and WUPyV in nasopharyngeal aspirate pediatric samples 180
Single-Step IGHV Next-Generation Sequencing Detects Clonality and Somatic Hypermutation in Lymphoid Malignancies: A Phase III Diagnostic Accuracy Study 179
SNPs array karyotyping reveals a novel recurrent 20p13 amplification in primary myelofibrosis. 179
CDKN1B/P27 expression in peripheral T-cell lymphoma not otherwise specified 179
BCL10 down-regulation in peripheral T-cell lymphomas. 178
Pathobiology of hodgkin lymphoma. 177
Prompt resolution of nasal aspergillosis with intranasal instillation of liposomal amphotericin-B (amBisome) and granulocyte transfusions 175
SNPs Array Karyotyping in Non-Hodgkin Lymphoma 174
Unveiling another missing piece in EBV-driven lymphomagenesis: EBV-encoded microRNAs expression in EBER-negative Burkitt lymphoma cases 173
Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma 172
Beyond NPM-anaplastic lymphoma kinase driven lymphomagenesis 172
Characterization of a new monoclonal antibody against PAX5/BASP in 1525 paraffin-embedded human and animal tissue samples. 172
Molecular profiling of aggressive lymphomas 171
Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana Linfomi 171
Clonality analysis of immunoglobulin gene rearrangement by next-generation sequencing in endemic burkitt lymphoma suggests antigen drive activation of bcr as opposed to sporadic burkitt lymphoma 170
Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. 168
Primary cardiac non-Hodgkin lymphoma presenting with atrial flutter and pericardial effusion. 168
An observational study of once weekly intravenous ganciclovir as CMV prophylaxis in heavily pre-treated chronic lymphocytic leukemia patients receiving subcutaneous alemtuzumab. 168
Chronic inflammation, including Autoimmunity, and Lymphomagenesis. 168
Pathobiology of anaplastic large cell lymphoma. 167
Blastic plasmacytoid dendritic cell neoplasm: is it time to redefine the standard of care? 167
Anti-leukemic and anti-GVHD effects of campath-1H in acute lymphoblastic leukemia relapsed after stem-cell transplantation. 167
Cytoplasmic mutated nucleophosmin (NPM1) in blast crisis of chronic myeloid leukaemia. 166
Dose increase of imatinib mesylate may overcome acquired resistance in bcr/abl-positive acute lymphoid leukaemia 166
Another look at follicular lymphoma: immunophenotypic and molecular analyses identify distinct follicular lymphoma subgroups 165
Molecular genetics of peripheral T-cell lymphomas 165
Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells) 165
The cell of origin of Burkitt lymphoma: germinal centre or not germinal centre? 164
Linfomi a cellule T periferiche NAS: nuovo indice prognostico. 162
Evaluation of Modified PEG-Anilinoquinazoline Derivatives as Potential Agents for EGFR Imaging in Cancer by Small Animal PET. 162
Presence or the Emergence of a F317L BCR-ABL Mutation May Be Associated With Resistance to Dasatinib in Philadelphia Chromosome Positive Leukemia 162
Targeted molecular therapy in peripheral T-cell lymphomas 161
The Prognostic value of tumor and microenvironment markers in classifical Hodgkin lymphoma (CHL) patients. 161
Vascular endothelial growth factor A (VEGFA) expression in mycosis fungoides 159
Preferential usage of specific immunoglobulin heavy chain variable region genes with unmutated profile and advanced stage at presentation are common features in patients with chronic lymphocytic leukemia from Senegal 159
Pathobiology of ALK-negative anaplastic large cell lymphoma. 158
The development of more than one histologic type of lymphoma in the same patient is frequent and confers a worse prognosis 157
The presence of Epstein-Barr virus significantly impacts the transcriptional profile in immunodeficiency-associated Burkitt lymphoma 156
Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients 156
The alteration of lipid metabolism in Burkitt lymphoma identifies a novel marker: adipophilin. 155
Pathobiology of Epstein-Barr virus-driven peripheral T-cell lymphomas 154
Resolving the diagnostic dilemma of T-cell clonal expansion after hematopoietic stem cell transplantation in T-cell lymphoma patients by TCR-gamma next generation sequencing 154
Gene expression profile predicts response to the combination of tosedostat and low-dose cytarabine in elderly AML 153
Hsa-miR-15a and Hsa-miR-16-1 Expression Is Not Related to Proliferation Centers Abundance and Other Prognostic Factors in Chronic Lymphocytic Leukemia 150
Molecular monitoring to identify a threshold of CBFbeta/MYH11 transcript below which continuous complete remission of acute myeloid leukemia inv16 is likely. 149
Totale 22.096
Salva come PNG Salva come JPEG
Categoria #
all - tutte 102.801
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 102.801
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.392 0 0 0 0 0 0 0 0 0 209 195 988
2021/20224.470 353 178 292 365 443 293 95 280 225 373 909 664
2022/20235.150 641 704 254 655 313 385 164 266 866 141 456 305
2023/20242.205 124 248 121 172 151 299 172 179 91 187 199 262
2024/20255.472 325 876 480 416 834 294 580 204 105 262 169 927
2025/202610.647 761 921 1.105 1.047 1.388 684 1.028 350 2.530 833 0 0
Totale 41.051